{"id":10569,"date":"2022-05-04T21:39:05","date_gmt":"2022-05-04T21:39:05","guid":{"rendered":"http:\/\/depts.washington.edu\/kenyares\/?page_id=10569"},"modified":"2022-09-30T23:22:41","modified_gmt":"2022-09-30T23:22:41","slug":"tecla-temu-md-phd","status":"publish","type":"page","link":"https:\/\/depts.washington.edu\/kenyares\/about\/who-we-are\/krtc-affiliates\/tecla-temu-md-phd\/","title":{"rendered":"Tecla Temu MD, PhD"},"content":{"rendered":"<div id=\"pl-10569\"  class=\"panel-layout\" ><div id=\"pg-10569-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-10569-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-10569-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2>Assistant Professor, Global Health, University of Washington<\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-10569-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-10569-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-10569-1-0-0\" class=\"so-panel widget widget_sow-image panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-image so-widget-sow-image-default-8b5b6f678277-10569\"\n\t\t\t\n\t\t>\n<div class=\"sow-image-container\">\n\t\t<img \n\tsrc=\"https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu.png\" width=\"668\" height=\"684\" srcset=\"https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu.png 668w, https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu-293x300.png 293w, https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu-50x50.png 50w, https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu-250x256.png 250w, https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu-300x307.png 300w, https:\/\/depts.washington.edu\/kenyares\/wp-content\/uploads\/2022\/05\/Tecla-Teu-620x635.png 620w\" sizes=\"(max-width: 668px) 100vw, 668px\" title=\"Tecla Teu\" alt=\"\" \t\tclass=\"so-widget-image\"\/>\n\t<\/div>\n\n<\/div><\/div><\/div><div id=\"pgc-10569-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-10569-1-1-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span style=\"font-weight: 400;\">Dr. Tecla Temu, MD, PhD, is a clinical assistant professor in the Department of Global Health. Her interests and expertise fall under the broad umbrella of global cardiovascular disease (CVD) and include investigating the pathogenesis of CVD in HIV and CVD screening and treatment interventions. <\/span><span style=\"font-weight: 400;\">Dr. Temu is a translational science CVD researcher with a background in pathobiology, immunology, and epidemiology. She is passionate about CVD and her primary research goals are directed towards understanding the epidemiology of CVD and interactions with infectious disease in sub-Saharan Africa. As a postdoctoral research fellow in UW, she has been involved in multiple projects to identify genetic and behavioral determinants of CVD among adults living with and without HIV in Kenya. Recently, she transitioned her research focus to investigate the pathogenesis of CVD in people living with HIV (PLWH), a pressing problem that has received limited attention, particularly in low and middle-income countries. Dr. Temu is dedicated to continuing research on the pathogenesis of CVD to identify novel markers and to develop risk scoring systems that are contextually relevant to African populations so that those at higher risk can be identified, screened, and treated.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">To date, Dr. Temu has been a Principal Investigator (PI) of 10 studies including an R21, two NIH diversity supplement grants, and two international career development awards from The European and Developing Countries Clinical Trials Partnership program (EDCTP) and the GlaxoSmithKline NCD open lab Africa program to conduct cardiovascular research in Kenya. She was recently awarded a 5-year NIH K01 from the National Heart, Lung, and Blood Institute (NHLBI) and a Center for AIDS Research (CFAR) supplement to assess for the role of gut microbiota and metabolomes in contributing to CVD risk among PLWH. In addition, she was awarded a CFAR New Investigator Award (NIA) to investigate the immunopathogenesis of hypertension in Kenya.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-10569-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-10569-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-10569-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"3\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\">Publications<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<!-- updating from pubmed last update:2026-04-29 17:19:11 --><ol><li>Obare, LM, Temu, TM, Ding, T, Mtui, J, Kityo, C, Nazzinda, R <i>et al.<\/i>. Associations Between B-Cell Subsets and Subclinical Coronary Artery Disease in Ugandans With and Without HIV. Open Forum Infect Dis. 2026;13 (3):ofag107. doi: <a href='http:\/\/dx.doi.org\/10.1093\/ofid\/ofag107'>10.1093\/ofid\/ofag107<\/a>. PubMed <a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/41859698'>PMID:41859698<\/a> PubMed Central <a href='http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12996881'>PMC12996881<\/a>.<\/li><li>Cobe\u00f1a-Reyes, J, Wanjalla, CN, Feria, MG, Simmons, J, Temu, T, Nochowicz, C <i>et al.<\/i>. Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary Artery Disease in a Ugandan Cohort Using Mass Cytometry. Pathog Immun. 2026;11 (1):14-38. doi: <a href='http:\/\/dx.doi.org\/10.20411\/pai.v11i1.945'>10.20411\/pai.v11i1.945<\/a>. PubMed <a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/41640845'>PMID:41640845<\/a> PubMed Central <a href='http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12867109'>PMC12867109<\/a>.<\/li><li>Mugambi, C, Mbogo, L, Sinkele, W, Gitau, E, Temu, T, Farquhar, C <i>et al.<\/i>. HIV risk and oral pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in Nairobi: a cross-sectional study. BMC Infect Dis. 2026;26 (1):269. doi: <a href='http:\/\/dx.doi.org\/10.1186\/s12879-025-12490-1'>10.1186\/s12879-025-12490-1<\/a>. PubMed <a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/41492124'>PMID:41492124<\/a> PubMed Central <a href='http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12874915'>PMC12874915<\/a>.<\/li><li>Cobe\u00f1a-Reyes, J, Wanjalla, CN, Feria, MG, Simmons, J, Temu, T, Nochowicz, C <i>et al.<\/i>. Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary Artery Disease in a Ugandan Cohort Using Mass Cytometry. bioRxiv. 2025; :. doi: <a href='http:\/\/dx.doi.org\/10.1101\/2025.08.25.672210'>10.1101\/2025.08.25.672210<\/a>. PubMed <a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40909531'>PMID:40909531<\/a> PubMed Central <a href='http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12407895'>PMC12407895<\/a>.<\/li><li>Obare, LM, Simmons, J, Oakes, J, Zhang, X, Nochowicz, C, Priest, S <i>et al.<\/i>. CD3+ T-cell: CD14+ monocyte complexes are dynamic and increased with HIV and glucose intolerance. J Immunol. 2025;214 (3):516-531. doi: <a href='http:\/\/dx.doi.org\/10.1093\/jimmun\/vkae054'>10.1093\/jimmun\/vkae054<\/a>. PubMed <a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40073149'>PMID:40073149<\/a> PubMed Central <a href='http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11952877'>PMC11952877<\/a>.<\/ol><a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Tecla+Temu'>Search PubMed<\/a>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Assistant Professor, Global Health, University of Washington Dr. Tecla Temu, MD, PhD, is a clinical assistant professor in the Department of Global Health. Her interests and expertise fall under the broad umbrella of global cardiovascular disease (CVD) and include investigating the pathogenesis of CVD in HIV and CVD screening and treatment interventions. Dr. Temu is&#8230; <a href=\"https:\/\/depts.washington.edu\/kenyares\/about\/who-we-are\/krtc-affiliates\/tecla-temu-md-phd\/\">Read More<\/a><\/p>\n","protected":false},"author":20,"featured_media":0,"parent":10633,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_no-sidebar-page.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-10569","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/pages\/10569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/comments?post=10569"}],"version-history":[{"count":9,"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/pages\/10569\/revisions"}],"predecessor-version":[{"id":11205,"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/pages\/10569\/revisions\/11205"}],"up":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/pages\/10633"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/kenyares\/wp-json\/wp\/v2\/media?parent=10569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}